Benjamin R. Fisher
View detailed information about Benjamin R. Fisher, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Health Technology 3 (Gastrorenal, ObGyn, General Hospital, and Urology Devices).
Documents (10)
- 483 · Brunswick Farms Inc · May 10, 2011
- WARNING LETTER · Angiplast Private Limited · January 30, 2020
- WARNING LETTER · Tenderneeds Fertility LLC · December 13, 2019
- WARNING LETTER · ITL Asia Pacific Sdn Bhd · May 30, 2019
- WARNING LETTER · Jiangsu JDC Medical Devices Co., Ltd. · September 19, 2019
- WARNING LETTER · Creation Technologies · March 5, 2020
- WARNING LETTER · E-Care Technology Corp. · October 25, 2019
- WARNING LETTER · Okamoto Rubber Products Co., Ltd. · November 7, 2019
- WARNING LETTER · Dongguan Microview Medical Technology Co., LTD · June 27, 2019
- WARNING LETTER · Indus Medicare Limited · January 23, 2020
Person Information
Name
Benjamin R. Fisher
Title
Office Director
Role
Regulatory Personnel
ID: 8c1a550d-bda4-4ff3-b77c-5a3bf2a8cf37
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.